Status:
WITHDRAWN
A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy
Lead Sponsor:
Mayo Clinic
Conditions:
Refractory Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to use functional imaging to study the mechanisms of the anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS).
Detailed Description
Researchers are testing how changing the settings on deep brain stimulation device (DBS) can help reduce the number and severity of seizures. Functional imaging will be used to study the mechanisms of...
Eligibility Criteria
Inclusion
- \- Patients who have previously undergone anterior thalamic nucleus deep brain stimulation (DBS) for refractory epilepsy.
Exclusion
- \- Contraindication to MRI; prior brain resective surgery or large area of brain tissue loss (e.g., large area infarction).
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04753983
Start Date
September 1 2022
End Date
May 1 2024
Last Update
November 1 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.